Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2000
10/26/2000CA2369470A1 Method for detecting and modifying mismatches and mutations in nucleic acid
10/26/2000CA2369342A1 Carbohydrate-modifying enzymes
10/26/2000CA2366093A1 Combinatorial chemical library supports having indicia at coding positions and methods of use
10/26/2000CA2365707A1 Compound screening method
10/26/2000CA2365523A1 Identification of sortase gene
10/26/2000CA2365497A1 Compound assay using nematodes
10/26/2000CA2365449A1 Inhibitor of the growth of androgen-independent tumor
10/26/2000CA2364209A1 49 human secreted proteins
10/26/2000CA2363994A1 Diagnosis of a person's risk for developing atherosclerosis or diabetic retinopathy
10/26/2000CA2349827A1 Pharmacological targeting of mrna cap formation
10/25/2000EP1046717A2 Method and probes for determining a concentration of target nucleic acid molecules and method for analyzing data obtained by the method
10/25/2000EP1046716A1 Methods for quantitating high-density lipoprotein cholesterol
10/25/2000EP1046715A1 Interaction of vascular-endothelial protein-tyrosine phosphatase with the angiopoietin receptor tie-2
10/25/2000EP1046714A2 A method and kit for measuring mitochondrial activity
10/25/2000EP1046713A2 Method for the selection of adhesive lactobacilli strains having therapeutical properties and strains obtained by said method
10/25/2000EP1046649A1 Solid phase nucleic acid labeling by transamination
10/25/2000EP1046648A1 3'-deoxyribonucleotide derivatives
10/25/2000EP1046038A1 Use of mass fingerprinting for identification of protein affinity ligands
10/25/2000EP1046036A1 Methods for obtaining probes of peptide function
10/25/2000EP1046034A1 Method for identifying validated target and assay combinations
10/25/2000EP1045927A1 Multiplex vgid
10/25/2000EP1045926A2 Gene family with transformation modulating activity
10/25/2000EP1045925A1 Enzyme-specific cleavable polynucleotide substrate and assay method
10/25/2000EP1045924A1 Method for determination of the gross nitrogen-mineralization rate of a soil sample
10/25/2000EP1045923A1 Method for isolation and identification of (escherichia coli) 0157:h7 and plating media for said process
10/25/2000EP1045918A1 G protein-related kinase mutants in essential hypertension
10/25/2000EP1045914A1 Testis-specific human svph1-8 proteinase
10/25/2000EP1045913A2 Human protease molecules
10/25/2000EP1045910A1 Trypanosoma cruzi antigen, gene encoding therefor, and methods of detecting and treating chagas disease
10/25/2000EP1045908A2 Human urotensin ii
10/25/2000EP1045905A2 Il-17rh dna and polypeptides
10/25/2000EP1045904A1 Fatty acid transport proteins
10/25/2000EP1045899A2 Method of determining the function of nucleotide sequences and the proteins they encode by transfecting the same into a host
10/25/2000EP1045897A1 Enzyme catalyzed therapeutic agents
10/25/2000EP1045859A1 NOVEL SURFACE PROTEIN OF $i(NEISSERIA MENINGITIDIS)
10/25/2000EP1045857A1 MULTIPLE DRUG RESISTANCE GENE atrC OF ASPERGILLUS NIDULANS
10/25/2000EP1045764A1 Labeling technique for countering product diversion and product counterfeiting
10/25/2000EP0750626B1 Corpuscles of stannius protein, stanniocalcin
10/25/2000CN2402685Y Convenient negative pressure selection culture apparatus
10/25/2000CN1271389A Nucleic acid vaccines encoding G protein of respiratory syncytial virus
10/25/2000CN1271387A Mammalian cytokine: interleukin-B30 and related reagents
10/25/2000CN1271099A Integrated viral hepatitis diagnosing chip and its preparation
10/25/2000CN1271098A Integrated venereal disease diagnosing chip and its preparation
10/25/2000CN1271020A Effective test HIV-1 and HIV-2 oligonucleotide reverse transcirpt initiator and its using method
10/25/2000CN1271019A Increasing specificity of nuclein acid expansion by carrier nucleic acid
10/25/2000CN1271012A New human cation transfer related protein and its code sequence
10/25/2000CN1271011A New human phosphoric triesterase related protein and its code sequence
10/25/2000CN1271010A New human aromatic esterase protein and its code sequence
10/25/2000CN1271009A New human diacyl glyceropyrophosphate phosphatase protein and its code sequence
10/25/2000CN1271008A New human salt-resisting protein subunit protein and its code sequence
10/25/2000CN1271007A New human chitinase protein and its code sequence
10/25/2000CN1271006A New human proteinase subunit protein and its code sequence
10/25/2000CN1271005A New human cytochrome protein and its code sequence
10/25/2000CN1270962A Improved method for preparing DNA from blooc serum and plasma
10/25/2000CN1057797C Method for quantitative determination of specificity of gene amplification product by solid-phae hybridization enzyme color development reaction
10/24/2000US6138077 Method, apparatus and computer program product for determining a set of non-hybridizing oligonucleotides
10/24/2000US6136962 Covalent attachment of unmodified nucleic acids to silanized solid phase surfaces
10/24/2000US6136957 Antibodies which bind granulocyte-macrophane colony-stimulating factor receptor
10/24/2000US6136953 Human antiproliferative polypeptide for the detection of vascular injuries
10/24/2000US6136779 Methods of specifically transcriptionally modulating the expression of gene of interest
10/24/2000US6136604 Oligonucleotides which target preferential nucleotide sequences for the suppression on expression of human enzyme; for treatment of skin disorders; anticarcinogenic agents; antiinflammatory agents
10/24/2000US6136602 Nucleotide sequences which can hybridize to preferential target nucleic acids; for the suppression of the expression of genes associated with antibiotic resistance and the prevention of bacterial infections
10/24/2000US6136601 Targeted mutagenesis in living cells using modified oligonucleotides
10/24/2000US6136597 Nucleotide sequences comprising regulatory sequences for the efficient transferring of nucleic acid sequences to cytoplasm and expression of heterologous nucleic acids
10/24/2000US6136596 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
10/24/2000US6136583 Amidase
10/24/2000US6136581 Kinase genes and uses
10/24/2000US6136572 Recombinant KAT enzyme and process for its preparation
10/24/2000US6136570 Method for producing RNA viruses from cDNA
10/24/2000US6136568 De novo polynucleotide synthesis using rolling templates
10/24/2000US6136555 Purification method and apparatus
10/24/2000US6136554 Rapid and cost effective method by inoculating nutrient culture containing concentration of propionic acid and/or its salts which inhibit other bacteria and chromogenic compounds, incubating, detecting colored colonies; escherichia
10/24/2000US6136543 Hybridizing primer to dna; performing complementary strand extension using polymerase to incorporate chemically modified, chain stopping nucleotides to 3' end; determining base; modifying nucleotide to allow extension; repeating
10/24/2000US6136542 Method for screening for inhibitors and activators of type III secretion machinery in gram-negative bacteria
10/24/2000US6136540 Automated fluorescence in situ hybridization detection of genetic abnormalities
10/24/2000US6136539 Compositions and methods for the inhibition of MUC-5 mucin gene expression
10/24/2000US6136538 Silent inducible virus replicons and uses thereof
10/24/2000US6136537 Gene expression analysis
10/24/2000US6136535 Continuous amplification reaction
10/24/2000US6136534 Methods for sensitive detection of reverse transcriptase
10/24/2000US6136533 Detecting a nucleic acid by reacting with nucleic acid probe having a scissile linkage, an enzyme for cleaving double stranded nucleic acids and a ribosomal protein; allowing hybridization, cleavage, and cycling; determining cleavage
10/24/2000US6136532 Methods for treating bipolar mood disorder associated with markers on chromosome 18q
10/24/2000US6136531 Labeling single-stranded nucleic acids isolated from sample with chemical group bound by a linker, hybridizing in solution to labeled polynucleotide probe, immobilizing hybrid onto solid phase by chemical group, measuring label
10/24/2000US6136530 Compositions and methods for assessing risk factors in Alzheimer's disease
10/24/2000US6136529 Nucleic acid probes to Mycobacterium avium complex
10/24/2000US6136528 Multiple sclerosis virus
10/24/2000US6136527 Polypeptides derived from proteins of the hepatitis C virus, test kits containing these polypeptides and vaccines against infections of hepatitis C viruses
10/24/2000US6136233 For electrochemiluminescence (ecl)-based assay used in quantitation of classical clinical chemistry analytes, detecting, analyzing and monitoring analytes
10/24/2000US6135941 Human immune system associated molecules
10/24/2000CA2220873C Method for reproducing in vitro the rna-dependent rna polymerase and terminal nucleotidyl transferase activities encoded by hepatitis c virus (hcv)
10/24/2000CA2199445C Disposable test kit apparatus and method for bacteria
10/24/2000CA2185535C A method for detecting and/or optionally quantifying and/or separating apoptotic cells in or from a sample
10/24/2000CA2124814C 2'-deoxy-isoquanosines, isosteric analogues and isoquanosine derivatives as well as their use
10/24/2000CA2113106C Fluorescent microparticles with controllable enhanced stokes shift
10/24/2000CA1341125C Dna encoding serotonin 1c (5ht1c) receptor, isolated 5ht1c receptor, mammalian cells expressing same and uses thereof
10/19/2000WO2000062247A1 Histological reconstruction and automated image analysis
10/19/2000WO2000062077A1 Procoagulant assay
10/19/2000WO2000062076A1 Galectin expression is induced in cirrhotic liver and hepatocellular carcinoma
10/19/2000WO2000062072A1 Homogeneous detection and/or determination method for a chemical or physico-chemical interaction
10/19/2000WO2000062071A1 Diagnostic and therapeutic use of antibodies against the urokinase receptor